About
Micropos Medical AB (publ) is a Swedish medical device company based in Gothenburg, founded in 2003. The company specializes in technology that enhances radiotherapy treatment for prostate cancer. Its primary product, the Raypilot® System, is an electromagnetic positioning system that enables real-time tumor tracking during radiation therapy. This system improves treatment precision by continuously localizing prostate tumor movements and outlining the urethra in real-time 3D, which helps reduce the risk of damaging healthy tissue. The Raypilot System is CE marked and FDA 510(k) approved, with sales in 10 countries across Europe and the USA. It has been used to treat over 270 patients, demonstrating its effectiveness in clinical settings. Micropos Medical primarily serves radiation oncology clinics and hospitals, receiving positive feedback from healthcare professionals for its ability to enhance treatment safety and support hypofractionation protocols. The company reported revenues of approximately 3.3 million SEK in 2021 and has been publicly listed on the Spotlight Stock Market since 2009.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2003
Location
11 Adolf Edelsvaerds gata, Gothenburg, Vaestra Goetalands laen, Sweden, 41451